Skip to main content

Time in Range News

Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in the target range, usually between 70 and 180 mg/dl.

Mark Harmel, MPH, CDCES, discusses how his clinic is moving to telemedicine in the time of COVID-19 and how to share data from many diabetes devices
dQ&A surveyed 2,540 CGM users with type 1 or type 2 diabetes to find out how aware they are of their own time in range: 87% of respondents knew how much time they...
Dr. Anne Peters shares insights on how healthcare professionals can help people ease the challenges of managing diabetes during COVID and how the shift to telemedicine...
We interviewed Dr. Partha Kar to learn about how people are using time in range in his clinic and what obstacles our society will need to overcome to promote wider use...
Rybelsus, a GLP-1 agonist pill already approved in Europe and the US, has just been approved by Health Canada for adults with type 2 diabetes
Health Canada authorizes the latest temporary approval for CGM during the pandemic: the Dexcom G6 is now available to pregnant women with diabetes
Expert physicians share a few of the benefits of virtual appointments for people living with diabetes
Enroll in Level2 to get a CGM, a Fitbit activity tracker, and easily accessible virtual health coaching; the program is designed to help people achieve type 2 diabetes...
In-person visits, lab tests, and finger stick documentation are no longer required at present to get a CGM
Dive into AGP if you haven’t already! In our third video on understanding your ambulatory glucose profile (AGP) report, Dr. Carlson from the International Diabetes...
Though A1C has long been used as the primary metric for evaluating someone’s estimated average blood sugar, the glucose management indicator (GMI) is an alternative that...
The Association of Diabetes Care and Education Specialists' 2020 conference covered how to use CGM to adjust insulin during exercise, how to reduce fear of hypoglycemia...
Tandem’s Control-IQ hybrid closed loop system will soon become the first automated delivery system available to people with type 1 diabetes in Canada
Dr. Francine Kaufman breaks down what we need to know about avoiding hypoglycemia and hyperglycemia during and after exercise. She explains the recommendations and...
What is an ambulatory glucose profile (AGP) report and what can it tell you? In this video, Dr. Rich Bergenstal from the International Diabetes Center explains the...
Average A1C values differ between racial and ethnic groups – people of color have a higher average A1C compared to white people. This is because someone’s A1C value...
In part two of Dr. Bergenstal's video series on understanding your ambulatory glucose profile (AGP) report, he discusses how to use the information to help your diabetes...
Professor Thomas Danne and Kelly Close, two leading voices in the beyond A1C movement, came together to discuss the value of time in range for people with diabetes and...
Highlights from last week’s European Association for the Study of Diabetes’ (EASD) virtual 2020 conference included announcements on the Guardian Sensor 4 Continuous...
Fitbit’s new glucose tracking feature allows users to log blood glucose meter data alongside activity, sleep, food, and more in the Fitbit app. Learn how your daily...

Pages